PUBLIC COMPANY
saveLupin Ltd
updated 2mo ago
Lupinus, commonly known as lupin, lupine, or regionally bluebonnet, is a genus of plants in the legume family Fabaceae. The genus includes over 199 species, with centres of diversity in North and South America. Smaller centres occur in North Africa and the Mediterranean. They are widely cultivated both as a food source and as ornamental plants, but are invasive to some areas. For instance, lupine has become an ecological problem in Iceland since the beginning of the 21st century.
community read0 votes
🐶 often sniffed alongside
top 8- tagApproval116 co-mentions · 58 sources
- tagSmall Molecule57 co-mentions · 57 sources
- drugALDACTAZIDE48 co-mentions · 24 sources
- drugARBLI14 co-mentions · 14 sources
- drugLOSARTAN POTASSIUM14 co-mentions · 14 sources
- drugLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE14 co-mentions · 14 sources
- drugTRAMADOL HYDROCHLORIDE13 co-mentions · 13 sources
- drugtramadol hydrochloride ER13 co-mentions · 13 sources
pipeline
35
marketed
27
phase 3
1
catalysts ytd
10
approvals ytd
9
recalls ytd
0
Pipeline(35)
view full pipeline →pipeline depth35 products
1Phase 327Marketed7Unknown
Marketed
(amlodipine besylate + benazepril hydrochloride)
Hypertension
Marketed(emtricitabine + tenofovir alafenamide fumarate)
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Marketed(ethinylestradiol + norgestrel)
Female Contraception
Marketed(famotidine + ibuprofen)
Duodenal Ulcer
Marketed(ketorolac tromethamine + phenylephrine hydrochloride)
Ocular Pain (Eye Pain)
MarketedARMLUPEG
MarketedAntara
Hypercholesterolemia
MarketedCEFIXIME
Uncomplicated Cervical And Urethral Gonorrhea
MarketedDAPAGLIFLOZIN
Type 2 Diabetes
MarketedGLYCEROL PHENYLBUTYRATE
Urea Cycle Disorders
MarketedPennsaid
Osteoarthritis Pain
MarketedSuprax
Urinary Tract Infections
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2
- phase3Study to Compare Efficacy, Safety, and Immunogenicity of LUBT010 (Proposed Ranibizumab Biosimilar) and Lucentis® in Patients With Neovascular AMD
- phase3An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2 Who Have Completed MEX-DM-302 Study.
- phase3An Open-Label, Randomized, Cross-Over Study to Investigate the Efficacy and Safety of Mexiletine PR Compared to Mexiletine IR
- —Prospective, Long Term, Observational Study (Patient Registry) of Paediatric Myotonic Disorders
- N/AOpen-label Extension Study in Paediatric Patients Who Have Completed the MEX-NM-301 Study.
- —An Observational Study in Adult Patients With Non-dystrophic Myotonic Disorders
- phase3Open Label Study in Adolescents and Children With Myotonic Disorders
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that